A notable advancement in blood sugar treatment is emerging with the introduction of tirzepatide at a dosage of 45mg. This updated version builds upon the existing success of tirzepatide, a dual GIP and GLP-1 target, https://bookmarkforest.com/story21283116/groundbreaking-approach-tirzepatide-45mg-for-blood-sugar-control